Friday, November 27, 2015 7:32:17 PM
I know that it's been a very very long time in coming, but all KBLB needs now is an agreement with Vietnam to begin full scale production. I honestly believe India is in our future also, perhaps next year.
A friend of mine once told me that reaching a deal to commercialize would take years. I laughed at him. Boy, was he right or what!
I never imagined in my wildest dreams that it would take this long. Hopefully, that is the purpose of the CC, to let us know finally that the deal with Vietnam has been completed. That would be all I need to know.
Once that is completed, it is only a matter of time before Kim announces a contract. Then, earnings will follow, and we will shoot up to one dollar plus. I know that is a very simplistic description of how it will transpire, but it is close enough.
Kim would not have scheduled this CC unless he had something big to discuss. We have to imagine what that could be. One week from now at this time, we will know exactly what the CC entails. I just hope when the analytical posts begin to fly next Friday night and into Saturday and Sunday that you and I will be happy. Sure would be great to have wonderful news on the verge of Christmas.
Even Santa would be elated! Ho Ho Ho.....
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM